Bispecifics: Operationalizing Administration and Follow-Up

Justin LaPorte, PharmD, BCOP, introduces the purpose and objectives for the program.

A description and overview of the bispecific engager administration program at Northside Hospital.

Justin LaPorte, PharmD, BCOP, further explores his experience in developing and/or executing program development and SOPs for bispecific engagers.

Discussion of the roles and responsibilities of the health care provider (physician, APP), pharmacy staff, nursing staff, and financial counselors/clinic financial manager in bispecific engager administration.

Justin LaPorte, PharmD, BCOP, presents information on the grading and management of early and late adverse events.

A clinical pharmacist explains how their practice has evolved related to the administration of bispecific T-cell engagers.

Justin LaPorte, PharmD, BCOP, offers closing remarks following discussion on the administration of bispecific antibodies.